Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP869780.RAdYGVGjHnxJSQkKE1QAD1Lr1xxNSyb8XZYMDxD8sTQw8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP869780.RAdYGVGjHnxJSQkKE1QAD1Lr1xxNSyb8XZYMDxD8sTQw8130_assertion type Assertion NP869780.RAdYGVGjHnxJSQkKE1QAD1Lr1xxNSyb8XZYMDxD8sTQw8130_head.
- NP869780.RAdYGVGjHnxJSQkKE1QAD1Lr1xxNSyb8XZYMDxD8sTQw8130_assertion description "[Combined therapy of cisplatin and ATP11B-targeted siRNA significantly decreased cancer growth in mice bearing ovarian tumors derived from cisplatin-sensitive and -resistant cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869780.RAdYGVGjHnxJSQkKE1QAD1Lr1xxNSyb8XZYMDxD8sTQw8130_provenance.
- NP869780.RAdYGVGjHnxJSQkKE1QAD1Lr1xxNSyb8XZYMDxD8sTQw8130_assertion evidence source_evidence_literature NP869780.RAdYGVGjHnxJSQkKE1QAD1Lr1xxNSyb8XZYMDxD8sTQw8130_provenance.
- NP869780.RAdYGVGjHnxJSQkKE1QAD1Lr1xxNSyb8XZYMDxD8sTQw8130_assertion SIO_000772 23585472 NP869780.RAdYGVGjHnxJSQkKE1QAD1Lr1xxNSyb8XZYMDxD8sTQw8130_provenance.
- NP869780.RAdYGVGjHnxJSQkKE1QAD1Lr1xxNSyb8XZYMDxD8sTQw8130_assertion wasDerivedFrom befree-20150227 NP869780.RAdYGVGjHnxJSQkKE1QAD1Lr1xxNSyb8XZYMDxD8sTQw8130_provenance.
- NP869780.RAdYGVGjHnxJSQkKE1QAD1Lr1xxNSyb8XZYMDxD8sTQw8130_assertion wasGeneratedBy ECO_0000203 NP869780.RAdYGVGjHnxJSQkKE1QAD1Lr1xxNSyb8XZYMDxD8sTQw8130_provenance.